Presentation included announcement of the opening of the new manufacturing facility in Salt Lake City, UT SALT LAKE CITY , March 21, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that in his keynote address at the 5 th Annual MarketsandMarkets conference in... Read More